Literature DB >> 24333196

Long-term outcomes of direct and indirect below-the-knee open revascularization based on the angiosome concept in diabetic patients with critical limb ischemia.

Anne Lejay1, Yannick Georg2, Elvira Tartaglia2, Sébastien Gaertner3, Bernard Geny4, Fabien Thaveau2, Nabil Chakfe2.   

Abstract

BACKGROUND: We compared long-term outcomes of isolated below-the-knee (BTK) bypass revascularization in diabetic patients presenting with critical limb ischemia (CLI) with and without achieving the bypass on the artery corresponding to the territory of the lesion based on the angiosome concept. MATERIALS: We analyzed outcomes of 58 consecutive CLI limbs of 54 diabetic patients presenting with tissue loss who underwent isolated BTK bypasses from 2003 to 2009 for crural occlusive arterial disease. Bypasses were classified into direct and indirect groups based on the angiosome concept, whether feeding artery flow to the site of ischemic tissue loss was achieved or not. We compared median ulcer-healing time, survival, primary patency, and limb salvage rates between both groups by Kaplan-Meier analysis and log-rank test. Independent factors of major amputations were explored by univariate analysis. Variables with P < 0.2 in univariate analysis were submitted to multivariable analysis.
RESULTS: Median ulcer-healing time was 56 ± 18 days in direct group (n = 36) and 112 ± 45 days in indirect group (n = 22, P = 0.01). There was no difference between both groups in terms of survival or primary patency. Limb salvage rate was significantly higher in direct group than in indirect group: 91% vs. 66% at 1 year, 65% vs. 24% at 3 years, and 58% vs. 18% at 5 years, respectively (P = 0.03). After multivariable Cox proportional analysis, independent factors associated with major amputation were end-stage renal disease (P = 0.030) and C-reactive protein level (P = 0.025).
CONCLUSIONS: Achieving a direct arterial flow based on angiosome concept in CLI diabetic patients presenting with tissue loss appears to be important for ulcer healing and limb salvage.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24333196     DOI: 10.1016/j.avsg.2013.08.026

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  14 in total

Review 1.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

2.  Prospective study on clinical characteristics of Japanese diabetic patients with chronic limb-threatening ischemia presenting Fontaine stage IV.

Authors:  Mitsuyoshi Takahara; Shota Okuno; Izumi Nakamura; Osamu Iida; Takuya Tsujimura; Yosuke Hata; Yukihiro Fujita; Masakazu Haneda
Journal:  Diabetol Int       Date:  2019-06-17

Review 3.  Critical limb ischemia: current approach and future directions.

Authors:  Kanwar P Singh; Aditya M Sharma
Journal:  J Cardiovasc Transl Res       Date:  2014-05-15       Impact factor: 4.132

4.  Prognostic Value of Radiotracer-Based Perfusion Imaging in Critical Limb Ischemia Patients Undergoing Lower Extremity Revascularization.

Authors:  Ting-Heng Chou; Jessica L Alvelo; Sarah Janse; Xenophon Papademetris; Bauer E Sumpio; Carlos Mena-Hurtado; Albert J Sinusas; Mitchel R Stacy
Journal:  JACC Cardiovasc Imaging       Date:  2020-11-18

Review 5.  The comparative efficacy of angiosome-directed and indirect revascularisation strategies to aid healing of chronic foot wounds in patients with co-morbid diabetes mellitus and critical limb ischaemia: a literature review.

Authors:  Benedictine Y C Khor; Pamela Price
Journal:  J Foot Ankle Res       Date:  2017-06-28       Impact factor: 2.303

Review 6.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

7.  Infrapopliteal angioplasty using a combined angiosomal reperfusion strategy.

Authors:  G K Ambler; A L Stimpson; B G Wardle; D C Bosanquet; U K Hanif; S Germain; C Chick; N Goyal; C P Twine
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

Review 8.  Critical limb ischemia: current challenges and future prospects.

Authors:  Luigi Uccioli; Marco Meloni; Valentina Izzo; Laura Giurato; Stefano Merolla; Roberto Gandini
Journal:  Vasc Health Risk Manag       Date:  2018-04-26

9.  Is Angiosome-Targeted Angioplasty Effective for Limb Salvage and Wound Healing in Diabetic Foot? : A Meta-Analysis.

Authors:  Kum Ju Chae; Jin Yong Shin
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

10.  Radiotracer Imaging Allows for Noninvasive Detection and Quantification of Abnormalities in Angiosome Foot Perfusion in Diabetic Patients With Critical Limb Ischemia and Nonhealing Wounds.

Authors:  Jessica L Alvelo; Xenophon Papademetris; Carlos Mena-Hurtado; Sangchoon Jeon; Bauer E Sumpio; Albert J Sinusas; Mitchel R Stacy
Journal:  Circ Cardiovasc Imaging       Date:  2018-05       Impact factor: 7.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.